Literature DB >> 21074890

Syk mediates BCR- and CD40-signaling integration during B cell activation.

Haiyan Ying1, Zhenping Li, Lifen Yang, Jian Zhang.   

Abstract

CD40 is essential for optimal B cell activation. It has been shown that CD40 stimulation can augment BCR-induced B cell responses, but the molecular mechanism(s) by which CD40 regulates BCR signaling is poorly understood. In this report, we attempted to characterize the signaling synergy between BCR- and CD40-mediated pathways during B cell activation. We found that spleen tyrosine kinase (Syk) is involved in CD40 signaling, and is synergistically activated in B cells in response to BCR/CD40 costimulation. CD40 stimulation alone also activates B cell linker (BLNK), Bruton tyrosine kinase (Btk), and Vav-2 downstream of Syk, and significantly enhances BCR-induced formation of complex consisting of, Vav-2, Btk, BLNK, and phospholipase C-gamma2 (PLC-γ2) leading to activation of extracellular signal-regulated kinase (ERK), p38 mitogen-activated protein kinase, Akt, and NF-κB required for optimal B cell activation. Therefore, our data suggest that CD40 can strengthen BCR-signaling pathway and quantitatively modify BCR signaling during B cell activation.
Copyright © 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074890      PMCID: PMC3075491          DOI: 10.1016/j.imbio.2010.09.016

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  42 in total

Review 1.  The CD40/CD154 receptor/ligand dyad.

Authors:  U Schönbeck; P Libby
Journal:  Cell Mol Life Sci       Date:  2001-01       Impact factor: 9.261

Review 2.  Molecular mechanisms of CD40 signaling.

Authors:  G A Bishop; B S Hostager
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2001       Impact factor: 4.291

3.  Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling.

Authors:  K Tedford; L Nitschke; I Girkontaite; A Charlesworth; G Chan; V Sakk; M Barbacid; K D Fischer
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

Review 4.  B cell receptor signaling and autoimmunity.

Authors:  P Hasler; M Zouali
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

5.  A point mutation in CD28 distinguishes proliferative signals from survival signals.

Authors:  K Okkenhaug; L Wu; K M Garza; J La Rose; W Khoo; B Odermatt; T W Mak; P S Ohashi; R Rottapel
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

6.  Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation.

Authors:  G M Doody; S E Bell; E Vigorito; E Clayton; S McAdam; R Tooze; C Fernandez; I J Lee; M Turner
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

7.  Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines.

Authors:  L P Kane; P G Andres; K C Howland; A K Abbas; A Weiss
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

8.  Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

Authors:  E Hirsch; V L Katanaev; C Garlanda; O Azzolino; L Pirola; L Silengo; S Sozzani; A Mantovani; F Altruda; M P Wymann
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

Review 9.  Signaling by CD40 and its mimics in B cell activation.

Authors:  G A Bishop; B S Hostager
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

10.  Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha.

Authors:  Kaoru Saijo; Ingrid Mecklenbräuker; Angela Santana; Michael Leitger; Christian Schmedt; Alexander Tarakhovsky
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more
  11 in total

1.  Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL.

Authors:  Sarah E M Herman; Rashida Z Mustafa; Jennifer A Gyamfi; Stefania Pittaluga; Stella Chang; Betty Chang; Mohammed Farooqui; Adrian Wiestner
Journal:  Blood       Date:  2014-03-21       Impact factor: 22.113

2.  Syk is indispensable for CpG-induced activation and differentiation of human B cells.

Authors:  Mariann Kremlitzka; Bernadett Mácsik-Valent; Anna Erdei
Journal:  Cell Mol Life Sci       Date:  2014-12-28       Impact factor: 9.261

3.  Spatial coupling of JNK activation to the B cell antigen receptor by tyrosine-phosphorylated ezrin.

Authors:  Neetha Parameswaran; Gospel Enyindah-Asonye; Nayer Bagheri; Neilay B Shah; Neetu Gupta
Journal:  J Immunol       Date:  2013-01-21       Impact factor: 5.422

Review 4.  E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.

Authors:  Qingjun Liu; Hong Zhou; Wallace Y Langdon; Jian Zhang
Journal:  Cell Cycle       Date:  2014-05-14       Impact factor: 4.534

5.  TLR10 Is a B Cell Intrinsic Suppressor of Adaptive Immune Responses.

Authors:  Nicholas J Hess; Song Jiang; Xinyan Li; Yue Guan; Richard I Tapping
Journal:  J Immunol       Date:  2016-12-12       Impact factor: 5.422

6.  Altered gene expression in blood and sputum in COPD frequent exacerbators in the ECLIPSE cohort.

Authors:  Dave Singh; Steven M Fox; Ruth Tal-Singer; Stewart Bates; John H Riley; Bartolome Celli
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

7.  Modulation of B cell activation threshold mediated by BCR/CD40 costimulation by targeting Cbl-b for ubiquitination.

Authors:  Na Tang; Lifen Yang; Dongdong Li; Rushi Liu; Jian Zhang
Journal:  Biochem Biophys Rep       Date:  2019-04-28

8.  Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.

Authors:  Olivia Hatton; Stacie L Lambert; Sheri M Krams; Olivia M Martinez
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

9.  Tespa1 Deficiency Dampens Thymus-Dependent B-Cell Activation and Attenuates Collagen-Induced Arthritis in Mice.

Authors:  Yunliang Yao; Wei Huang; Xiaoyu Li; Xiawei Li; Jin Qian; Hui Han; Hui Sun; Xiangli An; Linrong Lu; Hongxing Zhao
Journal:  Front Immunol       Date:  2018-05-14       Impact factor: 7.561

10.  In vitro and in vivo study of the expression of the Syk/Ras/c‑Fos pathway in chronic glomerulonephritis.

Authors:  Jiarong Gao; Liangbing Wei; Junmei Song; Hui Jiang; Yachen Gao; Xi Wu; Shuangzhi Xu
Journal:  Mol Med Rep       Date:  2018-08-03       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.